The role of IL-10 in immune regulation during M. tuberculosis infection - PubMed (original) (raw)
Review
doi: 10.1038/mi.2011.7. Epub 2011 Mar 30.
Affiliations
- PMID: 21451501
- DOI: 10.1038/mi.2011.7
Free article
Review
The role of IL-10 in immune regulation during M. tuberculosis infection
P S Redford et al. Mucosal Immunol. 2011 May.
Free article
Abstract
During gaseous exchange the lungs are exposed to a vast variety of pathogens, allergens, and innocuous particles. A feature of the lung immune response to lung-tropic aerosol-transmitted bacteria such as Mycobacterium tuberculosis (Mtb) is a balanced immune response that serves to restrict pathogen growth while not leading to host-mediated collateral damage of the delicate lung tissues. One immune-limiting mechanism is the inhibitory and anti-inflammatory cytokine interleukin (IL)-10. IL-10 is made by many hematopoietic cells and a major role is to suppress macrophage and dendritic cell (DC) functions, which are required for the capture, control, and initiation of immune responses to pathogens such as Mtb. Here, we review the role of IL-10 on bacterial control during the course of Mtb infection, from early innate to adaptive immune responses. We propose that IL-10 is linked with the ability of Mtb to evade immune responses and mediate long-term infections in the lung.
Comment in
- The impact of mucosal infections on acquisition and progression of tuberculosis.
Perry S, Hussain R, Parsonnet J. Perry S, et al. Mucosal Immunol. 2011 May;4(3):246-51. doi: 10.1038/mi.2011.11. Epub 2011 Mar 16. Mucosal Immunol. 2011. PMID: 21412228 Free PMC article. Review.
Similar articles
- Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.
Bai X, Shang S, Henao-Tamayo M, Basaraba RJ, Ovrutsky AR, Matsuda JL, Takeda K, Chan MM, Dakhama A, Kinney WH, Trostel J, Bai A, Honda JR, Achcar R, Hartney J, Joosten LA, Kim SH, Orme I, Dinarello CA, Ordway DJ, Chan ED. Bai X, et al. Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5111-6. doi: 10.1073/pnas.1424302112. Epub 2015 Mar 27. Proc Natl Acad Sci U S A. 2015. PMID: 25820174 Free PMC article. - Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J, Yasmin H, Al-Ahdal MN, Bhakta S, Kishore U. Ferluga J, et al. Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review. - Blocking IL-10 receptor signaling ameliorates Mycobacterium tuberculosis infection during influenza-induced exacerbation.
Ring S, Eggers L, Behrends J, Wutkowski A, Schwudke D, Kröger A, Hierweger AM, Hölscher C, Gabriel G, Schneider BE. Ring S, et al. JCI Insight. 2019 Apr 18;5(10):e126533. doi: 10.1172/jci.insight.126533. JCI Insight. 2019. PMID: 30998505 Free PMC article. - Role of innate cytokines in mycobacterial infection.
Cooper AM, Mayer-Barber KD, Sher A. Cooper AM, et al. Mucosal Immunol. 2011 May;4(3):252-60. doi: 10.1038/mi.2011.13. Epub 2011 Mar 23. Mucosal Immunol. 2011. PMID: 21430655 Free PMC article. Review. - Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to M. Tuberculosis Infection.
Riccomi A, Piccaro G, Christensen D, Palma C, Andersen P, Vendetti S. Riccomi A, et al. Front Immunol. 2019 May 3;10:934. doi: 10.3389/fimmu.2019.00934. eCollection 2019. Front Immunol. 2019. PMID: 31130946 Free PMC article.
Cited by
- Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer.
Rossi JF, Lu ZY, Massart C, Levon K. Rossi JF, et al. Front Immunol. 2021 Feb 23;12:595722. doi: 10.3389/fimmu.2021.595722. eCollection 2021. Front Immunol. 2021. PMID: 33708198 Free PMC article. Review. - Lung Damage Induced by Plasmodium berghei ANKA in Murine Model of Malarial Infection is Mitigated by Dietary Supplementation with DHA-Rich Omega-3.
David-Vieira C, Carpinter BA, Bezerra-Bellei JC, Machado LF, Raimundo FO, Rodolphi CM, Renhe DC, Guedes IRN, Gonçalves FMM, Pereira LPMC, Ferreira MVR, Nascimento HLDS, Neto AF, Gomes FLR, Rocha VN, Castro JMA, Scopel KKG. David-Vieira C, et al. ACS Infect Dis. 2024 Oct 11;10(10):3607-3617. doi: 10.1021/acsinfecdis.4c00482. Epub 2024 Sep 20. ACS Infect Dis. 2024. PMID: 39303151 Free PMC article. - Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways.
Murray PJ, Smale ST. Murray PJ, et al. Nat Immunol. 2012 Oct;13(10):916-24. doi: 10.1038/ni.2391. Epub 2012 Sep 18. Nat Immunol. 2012. PMID: 22990889 Free PMC article. Review. - Resistance and Susceptibility Immune Factors at Play during Mycobacterium tuberculosis Infection of Macrophages.
Simper JD, Perez E, Schlesinger LS, Azad AK. Simper JD, et al. Pathogens. 2022 Oct 6;11(10):1153. doi: 10.3390/pathogens11101153. Pathogens. 2022. PMID: 36297211 Free PMC article. Review. - The human immune response to tuberculosis and its treatment: a view from the blood.
Cliff JM, Kaufmann SH, McShane H, van Helden P, O'Garra A. Cliff JM, et al. Immunol Rev. 2015 Mar;264(1):88-102. doi: 10.1111/imr.12269. Immunol Rev. 2015. PMID: 25703554 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- MC_U117565642/MRC_/Medical Research Council/United Kingdom
- P30 CA021765/CA/NCI NIH HHS/United States
- P30 CA21765/CA/NCI NIH HHS/United States
- AI62921/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources